Quick Answer
Alpha Tau Medical Ltd. reported Research And Development Expense of $32.07 million for the year ending 2025.
- Alpha Tau Medical Ltd. showed an increase of +18.7% in Research And Development Expense from 2024 to 2025.
- This data is from Alpha Tau Medical Ltd.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Alpha Tau Medical Ltd.'s Research And Development Expense has grown by 383.2%.
- Historical annual values: Fiscal year 2025: $32.07 million | Fiscal year 2024: $27.02 million | Fiscal year 2023: $26.42 million | Fiscal year 2022: $20.89 million | Fiscal year 2021: $11.45 million | Fiscal year 2020: $7.54 million | Fiscal year 2019: $6.64 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: